Mabion is a Finalist in the CDMO Leadership Awards 2025 in the Biologics category
- CDMO Leadership Awards 2025 help pharmaceutical and biotech companies identify trusted CDMO partners and serve as a benchmark for excellence in outsourced development and manufacturing services.
- Winning the award strengthens Mabion’s reputation as a high-quality CDMO, making us more attractive to potential clients. The recognition will boost our industry presence, opening doors to new business opportunities and partnerships.
Mabion has been honored as a Finalist in the Biologics – International category of the 2025 CDMO Leadership Awards, which recognize excellence in the industry. This distinction is based on evaluations from global pharmaceutical and biotech clients who have collaborated with over 210 CDMOs on outsourced projects within the past 24 months. Clients provide ratings based on their recent experiences, and the feedback is analyzed to identify top-performing CDMOs in each category.
As a comprehensive biologics CDMO, Mabion provides drug development and manufacturing services to the pharmaceutical, biopharma, biotech and clinical industry. High level of integration and ability to address only selected stages from the entire CDMO service value chain. Our facilities located in central Poland, which operate in full compliance with GMP, GLP, GCP and ISO principles, can run laboratory, clinical and commercial scale manufacturing of biotherapeutics, providing the customers with high quality products at optimal efficiency and competitive pricing.
The CDMO Leadership Awards recognize the best contract development and manufacturing organizations across global and regional categories. These awards, organized by Life Science Connect and Orientation Marketing, highlight top-performing CDMOs across various categories, including Capabilities, Compatibility, Expertise, Quality, Reliability, and Service. It is an honor to be among a small group of awarded companies.
CDMO Leadership Awards Ceremony
The winners of the CDMO Champion Awards will be announced during DCAT Week at The POOL, in midtown Manhattan (99 East 52nd Street) on March 19. Our delegates, Adam Pietruszkiewicz, Chief Commercial Officer, and Marty Henehan, VP of Business Development – Head of North America will participate in the CDMO Leadership Awards Ceremony. Stay tuned!
Set up an appointment with our experts.
Prepared by:
